Roberts Glore & CO Inc Merck & Co., Inc. Transaction History

Roberts Glore & CO Inc

  • $328 Million
  • Q2 2024

A detailed history of Roberts Glore & CO Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Roberts Glore & CO Inc holds 5,205 shares of MRK stock, worth $529,088. This represents 0.2% of its overall portfolio holdings.

Number of Shares
5,205
Previous 5,349 2.69%
Holding current value
$529,088
Previous $705,000 8.65%
% of portfolio
0.2%
Previous 0.21%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$123.8 - $132.96 $17,827 - $19,146
-144 Reduced 2.69%
5,205 $644,000
Q4 2023

Feb 12, 2024
SELL
$100.18 - $109.02 $11,220 - $12,210
-112 Reduced 2.05%
5,349 $583,000
Q3 2023

Nov 13, 2023
SELL
$102.95 - $114.33 $8,750 - $9,718
-85 Reduced 1.53%
5,461 $562,000
Q1 2023

May 08, 2023
BUY
$102.94 - $114.86 $11,838 - $13,208
115 Added 2.12%
5,546 $590,000
Q4 2022

Feb 13, 2023
BUY
$87.44 - $112.11 $18,887 - $24,215
216 Added 4.14%
5,431 $602,000
Q2 2022

Aug 11, 2022
BUY
$83.49 - $94.64 $11,104 - $12,587
133 Added 2.62%
5,215 $475,000
Q4 2021

Feb 11, 2022
BUY
$72.28 - $90.54 $867 - $1,086
12 Added 0.24%
5,082 $389,000
Q3 2021

Nov 12, 2021
BUY
$71.68 - $78.83 $3,584 - $3,941
50 Added 1.0%
5,070 $381,000
Q2 2021

Aug 10, 2021
BUY
$70.31 - $77.77 $28,827 - $31,885
410 Added 8.89%
5,020 $390,000
Q1 2021

May 06, 2021
SELL
$68.86 - $81.11 $68,377 - $80,542
-993 Reduced 17.72%
4,610 $355,000
Q4 2020

Feb 09, 2021
SELL
$71.77 - $79.65 $3,588 - $3,982
-50 Reduced 0.88%
5,603 $458,000
Q2 2020

Aug 13, 2020
SELL
$70.42 - $80.13 $242,456 - $275,887
-3,443 Reduced 37.85%
5,653 $437,000
Q1 2020

May 11, 2020
SELL
$63.36 - $87.82 $19,008 - $26,345
-300 Reduced 3.19%
9,096 $699,000
Q4 2019

Feb 13, 2020
BUY
$77.58 - $87.54 $412,260 - $465,187
5,314 Added 130.18%
9,396 $854,000
Q1 2019

May 14, 2019
SELL
$69.58 - $79.36 $54,411 - $62,059
-782 Reduced 16.08%
4,082 $339,000
Q4 2018

Feb 08, 2019
SELL
$65.24 - $75.71 $29,357 - $34,069
-450 Reduced 8.47%
4,864 $372,000
Q1 2018

May 08, 2018
BUY
$50.96 - $59.23 $10,090 - $11,727
198 Added 3.87%
5,314 $289,000
Q4 2017

Feb 09, 2018
BUY
$51.62 - $61.64 $16,518 - $19,724
320 Added 6.67%
5,116 $288,000
Q3 2017

Nov 08, 2017
SELL
$58.67 - $63.13 $10,149 - $10,921
-173 Reduced 3.48%
4,796 $307,000
Q2 2017

Aug 15, 2017
BUY
N/A
4,969
4,969 $318,000

Others Institutions Holding MRK

# of Institutions
3,807
Shares Held
1.92B
Call Options Held
13.4M
Put Options Held
10.6M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $258B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Roberts Glore & CO Inc Portfolio

Follow Roberts Glore & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roberts Glore & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Roberts Glore & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email